Ep. 13: Edward Lanphier, chief editing officer

GuidePost, A Podcast Series from The CRISPR Journal
21/08/2019 40 min
Ep. 13: Edward Lanphier, chief editing officer

Listen "Ep. 13: Edward Lanphier, chief editing officer"

Descargar episodio Ver en sitio original

Episode Synopsis

The recently retired founding CEO of Sangamo Therapeutics, Edward Lanphier, shares stories from two decades at the helm of the first biotech company to develop and take genome editing, using zinc finger nucleases, into the clinic.

More episodes of the podcast GuidePost, A Podcast Series from The CRISPR Journal

GuidePost Ep. 20: Eben Kirksey, Human Futures and Gene Editing 05/01/2022
GuidePost Ep. 19: David Liu, Precision Chemistry on DNA 26/04/2021
GuidePost Ep. 18: Kevin Davies, CRISPR Chronicler 06/04/2021
GuidePost Ep. 17: Dame Kay Davies, Guidance for Heritable Genome Editing 27/10/2020
GuidePost Ep. 16: Luciano Marraffini, big time microbiologist 24/12/2019
GuidePost Ep. 15: Bartha Knoppers, bioethics and human rights 11/12/2019
GuidePost Ep. 14: George Church, triple threat (reader/writer/editor) 04/11/2019
Ep. 12: Dana Carroll, your moment of ZFN 06/08/2019
Ep. 11: Adam Bolt, editor-turned-director 09/07/2019
Ep. 10: Alexis Komor & Nicole Gaudelli, base editing’s tenacious duo 10/04/2019
© 2003-2025 ZARZA | AHEAD OF OUR TIME
privacy policy
In God we trust In God we trust
PreSales Questions? Click Here
or call our toll-free line at +1-888-5002068 Miami, Florida, USA